Release Date: 29/01/09 11:53 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 120.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%